Rebecca J. Leeman-Neill, MD

Soderquist CR, Patel N, Murty VV, Betman S, Aggarwal N, Young KH, Xerri L, Leeman-Neill R, Lewis SK, Green PH, Hsiao S, Mansukhani MM, Hsi ED, de Leval L, Alobeid B, Bhagat G. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract. Haematologica. 2019 Sep 26.

Leeman-Neill, R. J., S. H. Swerdlow, C. L. Burnes, M. A. Melan, M. N. Nikiforova, U. Surti, and N. Aggarwal. Low-level BCR-ABL1 transcripts in individuals without overt hematologic malignancy. Leuk Res. 2019 Jun;81:98-101.

Sun, Y., V. V. Murty, R. Leeman-Neill, C. Soderquist, D. Park, D. B. Neill, G. Bhagat, and B. Alobeid. 2019. Cytogenetic analysis of adult T-Cell leukemia/lymphoma: evaluation of a Caribbean cohort. Leuk Lymphoma. 2019 Jun;60(6):1598-1600.

Leeman-Neill, R. J., J. Lim, and U. Basu. The Common Key to Class-Switch Recombination and Somatic Hypermutation: Discovery of AID and Its Role in Antibody Gene Diversification. J Immunol. 2018 Nov 1;201(9):2527-2529

Chander, U, Leeman-Neill, RJ, Bhagat, G. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Curr Hematol Malig Rep. 2018 Aug;13(4):308-317.

Efanov AA, Brenner AV, Bogdanova TI, Kelly LM, Liu P, Little MP, Wald AI, Hatch M, Zurnadzy LY, Nikiforova MN, Drozdovitch V, Leeman-Neill RJ, Mabuchi K, Tronko MD, Chanock SJ, Nikiforov YE. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer. J Natl Cancer Inst. 2018 Apr 1;110(4):371-378.

Leeman-Neill, RJ and Bhagat, G. BCL6 as a therapeutic target for lymphoma. Expert Opin Ther Targets, 2018 Feb; 22(2):143-152.

Bogdanova, TI, Zurnadzhy, LY, Nikiforov, YE, Leeman-Neill, RJ, Tronko, MD, Chanock, S, Mabuchi, K, Likhtarov, IA, Kovgan, LM, Drozdovitch, V, Little, MP, Hatch, M, Zablotska, LB, Shpak, VM, McConnell, RJ, Brenner, AV. "Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort." Br. J. Cancer 2015 Dec; 113(11):1556-64.

Gibson, SE, Leeman-Neill, RJ, Jain, S, Piao, W, Cieply, KM, Swerdlow, SH. "Proliferation centers of chronic lymphocytic leukemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene." Br. J. Hematol 2016 Oct; 175(1):173-5.

Leeman-Neill, R.J., Kelly, L.M., Liu, P., Brenner, A.V., Little, M.P., Bogdanova, T.I., Evdokimova, V.N., Hatch, M., Zurnadzy, L.Y., Nikiforova, M.N., Yue, N.J., Zhang, M., Mabuchi, K., Tronko, M.D., Nikiforov, Y.E. "ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer." Cancer 2014 March; 120(6):799-807.

Leeman-Neill, R.J., Brenner, A.V., Little, M.P., Bogdanova, T.I., Maureen, H., Zurnadzy, L.Y., Mabuchi, K., Tronko, M.D., Nikiforov, Y.E. "RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with I-131 radiation dose and other characteristics." Cancer 2013 May; 119(10): 1792-9

Leeman-Neill, R.J., Seethala, R.R., Singh, S.V., Freilino, M.L., Bednash, J.S., Thomas, S.M., Panahandeh, M.C., Gooding, W.E., Joyce, S.C., Lingen, M.W., Neill, D.B., and Grandis, J.R. "Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma" Cancer Prev Res 2011 Feb; 4(2): 230-7

Wheeler, S.E., Suzuki, S., Thomas, S.M., Leeman-Neill, R.J., Chiosea, S.I., Kuan, C.T., Bigner, D.D., Gooding, W.E., Lai, S.Y., and Grandis, J.R. "Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation" Oncogene 2010 Sep; 29(37): 5135-45

Leeman-Neill, R.J., Cai, Q., Joyce, S.C., Thomas, S.M., Bhola, N.E., Neill, D.B., Arbiser, J.L., and Grandis, J.R. "Honokiol inhibits EGFR signaling and enhances antitumor effects of EGFR inhibitors" Clin Cancer Res 2010 May; 16(9): 2571-9

Leeman-Neill, R.J., Wheeler, S.E., Singh, S.V., Thomas, S.M., Seethala, R.R., Neill, D.B., Panahandeh, M.C., Hahm, E., Joyce, S.C., Sen, M., Cai, Q., Li, C., Johnson, D.E., and Grandis, J.R. "Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3" Carcinogenesis 2009 Nov; 30(11): 1848-56.

Li, C., Sen, M., Leeman-Neill, R.J., Man, D.S., Grandis, J.R., and Johnson, D.E., "Bortezomib upregulates activated STAT3 and synergizes with inhibitors of STAT3 to promote head and neck squamous cell carcinoma cell death" Mol. Cancer Ther. 2009 Aug; 8(8): 2211-20

Lui, V.W., Boehm, A., Koppikar, P., Leeman, R.J., Johnson, D., Ogagan, M., Childs, E., Freilino, M., Grandis, J.R., "Antiproliferative mechanisms of a transcription factor decoy targeting STAT3: the role of STAT1," Molec. Pharm. 2007 May; 71(5): 1435-43

Leeman, R.J., Lui, V.W., Grandis, J.R. "STAT3 as a therapeutic target in head and neck cancer." Expert Opin Biol Ther. 2006 Mar; 6(3):231-41.

Abromson-Leeman, S., Bronson, R., Luo, Y., Berman, M., Leeman, R., Leeman, J., Dorf, M., "T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis," Am. J. Pathol. 2004 Nov;165(5):1519-33

Jensen, B.A., Leeman, R.J., Schlezinger, J.J., Sherr, D.H., "Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study," Environ. Health. 2003 Dec 16; 2(1):16.